رجوع
35
63
نطاق اليوم
KWD 0.30
KWD 0.34
نطاق 52 أسبوعًا
KWD 0.18
KWD 0.43
حجم التداول
100
متوسط 50 يوم / 200 يوم
KWD 0.31
/
KWD 0.27
الإغلاق السابق
KWD 0.34
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 4.3 | 0.3 |
| P/B | 0.2 | 2.9 |
| ROE % | 4.5 | 3.7 |
| Net Margin % | 8.4 | 3.8 |
| Rev Growth 5Y % | 29.9 | 10.0 |
| D/E | 0.3 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
840 M | 0 |
| FY2028 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
1 B | 0 |
| FY2027 |
KWD 0.162
KWD 0.162 – KWD 0.162
|
2.7 B | 1 |
النقاط الرئيسية
Revenue grew 29.94% annually over 5 years — strong growth
ROE of 4.47% is below average
Debt/Equity of 0.34 — conservative balance sheet
Generating 182.32M in free cash flow
P/E of 4.33 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 37.78%
النمو
Revenue Growth (5Y)
29.94%
Revenue (1Y)-7.84%
Earnings (1Y)N/A
FCF Growth (3Y)15.48%
الجودة
Return on Equity
4.47%
ROIC3.98%
Net Margin8.42%
Op. Margin13.57%
الأمان
Debt / Equity
0.34
Current Ratio1.67
Interest Coverage5.00
التقييم
P/E Ratio
4.33
P/B Ratio0.19
EV/EBITDA3.96
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -7.84% | Revenue Growth (3Y) | -8.63% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 29.94% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.99B | Net Income (TTM) | 167.29M |
| ROE | 4.47% | ROA | 2.37% |
| Gross Margin | 34.60% | Operating Margin | 13.57% |
| Net Margin | 8.42% | Free Cash Flow (TTM) | 182.32M |
| ROIC | 3.98% | FCF Growth (3Y) | 15.48% |
| Safety | |||
| Debt / Equity | 0.34 | Current Ratio | 1.67 |
| Interest Coverage | 5.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 4.33 | P/B Ratio | 0.19 |
| P/S Ratio | 0.36 | PEG Ratio | -0.03 |
| EV/EBITDA | 3.96 | Dividend Yield | 0.00% |
| Market Cap | 724.45M | Enterprise Value | 1.07B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1.99B | 2.16B | 2.38B | 2.10B | 696.96M |
| Net Income | 167.29M | -116.11M | -528.48M | 287.55M | -386.88M |
| EPS (Diluted) | 0.06 | -0.06 | -0.28 | 0.15 | -0.25 |
| Gross Profit | 687.40M | 738.43M | 815.68M | 650.98M | 304.87M |
| Operating Income | 269.59M | 192.68M | 269.35M | 236.90M | 115.57M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 7.05B | 7.45B | 7.92B | 8.04B | 8.15B |
| Total Liabilities | 3.23B | 3.76B | 4.32B | 4.13B | 4.40B |
| Shareholders' Equity | 3.80B | 3.69B | 3.60B | 3.91B | 3.76B |
| Total Debt | 1.28B | 1.90B | 2.82B | 2.65B | 2.97B |
| Cash & Equivalents | 941.58M | 1.04B | 678.57M | 800.95M | 2.31B |
| Current Assets | 1.88B | 2.03B | 1.94B | 1.98B | 3.35B |
| Current Liabilities | 1.13B | 1.53B | 2.67B | 926.60M | 735.67M |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#547 of 827
#59 of 709
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026